Skip to main content
SpringerLink
Log in

Value of Angiotensin-Converting Enzyme Inhibitors to Prevent Sudden Death

  • Chapter
Cardiac Arrhythmias 2005

  • 653 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Garg R, Yusuf S (1995) Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials. JAMA 273:1450–1456

    Article  PubMed  CAS  Google Scholar 

  2. Flather MD, Yusuf S, Kober L et al (2000) Long term ACE-inhibitor therapy in patients with heart failure or left ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group. Lancet 355:1575–1581

    Article  PubMed  CAS  Google Scholar 

  3. Latini R, Tognoni G, Maggioni AP et al (2000) Clinical effects of early angiotensin converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: systematic overview of individual data from 96 712 randomized patients. Angiotensin Converting Enzyme Inhibitor Myocardial Infarction Collaborative Group. J Am Coll Cardiol 35:1801–1807

    Article  PubMed  CAS  Google Scholar 

  4. The Heart Outcomes Prevention Evaluation Study Investigators (HOPE) (2000) Effects of angiotensin converting enzyme inhibitor, ramipril, on cardiovascular events in high risk patients. N Engl J Med 342:145–153

    Article  Google Scholar 

  5. Anonymous (1998) Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100 000 patients in randomized trials. ACE Inhibitor Myocardial Infarction Collaborative Group. Circulation 97:2202–2212

    Google Scholar 

  6. Pfeffer MA, Braunwald E, Moye LA et al on behalf of the SAVE investigators (1992) Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular Enlargement Trial. N Engl J Med 327:669–677

    Article  PubMed  CAS  Google Scholar 

  7. Torp-Pedersen C, Kober L for the TRACE Study Group (1999) Effect of the ACE inhibitor trandolapril on life expectancy of patients with reduced left ventricular function after acute myocardial infarction. Lancet 354:9–12

    Article  PubMed  CAS  Google Scholar 

  8. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators (1993) Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 342:821–828

    Google Scholar 

  9. Cohn JN, Johnson G, Ziesche S et al (1991) A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 325:303–310

    Article  PubMed  CAS  Google Scholar 

  10. Anonymous (1991) Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. The SOLVD Investigators. N Engl J Med 325:293–302

    Article  Google Scholar 

  11. Domanski MJ, Exner DV, Craig BB et al (1999) Effect of angiotensin converting enzyme inhibition on sudden cardiac death in patients following acute myocardial infarction. A meta-analysis of randomized clinical trials. J Am Coll Cardiol 33:598–604

    Article  PubMed  CAS  Google Scholar 

  12. Anonymous (1994) GISSI-3: effects of lisinopril and transdermal glycerol trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico. Lancet 343:1115–1122

    Google Scholar 

  13. Anonymous (1995) ISIS-4 a randomized factorial trial assessing early oral captopril, oral mononitrate and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. Lancet 345:669–685

    Article  Google Scholar 

  14. Fox KM, EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators (2003) Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet 362:782–788

    Article  PubMed  CAS  Google Scholar 

  15. Teo KK, Mitchell LB, Pogue J et al (2004) Effect of ramipril in reducing sudden deaths and non fatal cardiac arrest in high-risk individuals without heart failure or left ventricular dysfunction. Circulation 110:1413–1417

    Article  PubMed  CAS  Google Scholar 

  16. Grassi G, Cattaneo BM, Seravalle G et al (1997) Effects of chronic ACE inhibition on sympathetic nerve traffic and baroreflex control of circulation in heart failure. Circulation 96:1173–1179

    PubMed  CAS  Google Scholar 

  17. Pognizd S (1994) Focal mechanisms underlying ventricular tachycardia during prolonged ischemic cardiomyopathy. Circulation 90:1441–1458

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. ANMCO Research Center, Florence, Italy

    G. Fabbri & A. P. Maggioni

Authors
  1. G. Fabbri
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. P. Maggioni
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Divisione di Cardiologia, Ospedale Umberto I, Via Circonvallazione 50, I-30174, Venezia Mestre

    Antonio Raviele MD

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag Italia

About this chapter

Cite this chapter

Fabbri, G., Maggioni, A.P. (2006). Value of Angiotensin-Converting Enzyme Inhibitors to Prevent Sudden Death. In: Raviele, A. (eds) Cardiac Arrhythmias 2005. Springer, Milano. https://doi.org/10.1007/88-470-0371-7_51

Download citation

  • DOI: https://doi.org/10.1007/88-470-0371-7_51

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-0370-5

  • Online ISBN: 978-88-470-0371-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation